Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.41 - $1.24 $72,137 - $218,170
-175,944 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$1.09 - $1.89 $111,180 - $192,780
-102,000 Reduced 36.7%
175,944 $191,000
Q2 2021

Aug 16, 2021

BUY
$2.63 - $3.67 $131,878 - $184,028
50,144 Added 22.01%
277,944 $733,000
Q1 2021

May 14, 2021

BUY
$2.82 - $5.6 $97,391 - $193,401
34,536 Added 17.87%
227,800 $820,000
Q3 2020

Nov 13, 2020

SELL
$2.39 - $3.43 $9,930 - $14,251
-4,155 Reduced 2.1%
193,264 $487,000
Q2 2020

Aug 14, 2020

BUY
$2.2 - $3.71 $85,690 - $144,504
38,950 Added 24.58%
197,419 $647,000
Q1 2020

May 15, 2020

BUY
$1.9 - $4.98 $36,398 - $95,401
19,157 Added 13.75%
158,469 $388,000
Q4 2019

Feb 14, 2020

BUY
$3.95 - $5.35 $168,155 - $227,754
42,571 Added 44.01%
139,312 $657,000
Q3 2019

Nov 14, 2019

BUY
$4.13 - $6.94 $26,832 - $45,089
6,497 Added 7.2%
96,741 $414,000
Q2 2019

Aug 15, 2019

SELL
$3.98 - $6.2 $47,449 - $73,916
-11,922 Reduced 11.67%
90,244 $0
Q1 2019

May 14, 2019

BUY
$2.0 - $4.4 $13,420 - $29,524
6,710 Added 7.03%
102,166 $0
Q4 2018

Feb 13, 2019

BUY
$1.61 - $3.62 $44,944 - $101,055
27,916 Added 41.33%
95,456 $178,000
Q2 2018

Aug 14, 2018

SELL
$3.02 - $4.94 $34,914 - $57,111
-11,561 Reduced 14.62%
67,540 $0
Q1 2018

May 14, 2018

BUY
$3.46 - $5.14 $51,799 - $76,950
14,971 Added 23.34%
79,101 $0
Q4 2017

Feb 09, 2018

BUY
$4.0 - $6.54 $35,200 - $57,552
8,800 Added 15.9%
64,130 $0
Q3 2017

Nov 13, 2017

BUY
$4.99 - $6.57 $276,096 - $363,518
55,330
55,330 $0

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $424M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.